Home › NDC Lookup › Labelers › Theratechnologies Inc.

Theratechnologies Inc. NDCs and Package Codes

This page lists NDC package records associated with labeler code 62064 (Theratechnologies Inc.) — including active listings, ingredients, drug names, strengths, dosage forms, package sizes, pricing data when available, and links to each individual NDC page.

Key stats

3
Package NDCs
5
Products
5
Active listings
0
Discontinued
2
Ingredients
0
Therapeutic classes
2
Dosage forms
0
With NADAC pricing

Portfolio

Top ingredients
tesamorelin 4
ibalizumab 1
By dosage form
KIT 4
INJECTION, SOLUTION 1

Browse records — 5 products

Drug / product Billing NDC NADAC / unit Status
EGRIFTA SV tesamorelin KIT Theratechnologies · NDC 62064-0241-30 · 1 KIT in 1 BOX (62064-241-30) * 30 BOTTLE in 1 TRAY / 10 mL in 1 BOTTLE * .5 mL in 1 VIAL 62064-0241-30 — On market View →
EGRIFTA SV tesamorelin KIT Theratechnologies · NDC 62064-0241-30 · 1 KIT in 1 BOX (62064-241-30) * 30 BOTTLE in 1 TRAY / 10 mL in 1 BOTTLE * .5 mL in 1 VIAL 62064-0241-30 — On market View →
EGRIFTA WR tesamorelin KIT Theratechnologies · NDC 62064-0381-04 · 1 KIT in 1 BOX (62064-381-04) * 1.3 mL in 1 VIAL (62064-371-01) * 30 mL in 1 BOTTLE 62064-0381-04 — On market View →
EGRIFTA WR tesamorelin KIT Theratechnologies · NDC 62064-0381-04 · 1 KIT in 1 BOX (62064-381-04) * 1.3 mL in 1 VIAL (62064-371-01) * 30 mL in 1 BOTTLE 62064-0381-04 — On market View →
TROGARZO ibalizumab 150 mg/mL INJECTION, SOLUTION Theratechnologies · NDC 62064-0122-02 · J1746 · 2 VIAL, SINGLE-USE in 1 CARTON (62064-122-02) / 1.33 mL in 1 VIAL, SINGLE-USE (62064-122-01) 62064-0122-02 — On market View →
Where does this data come from?
NDC package records, ingredients, strengths and forms come from the openFDA NDC Directory, grouped by the 5-digit labeler code; pricing is CMS NADAC. This is a factual data directory, not a manufacturer marketing page.